Grip Strength Chart: Average Scores by Age, Sex, and What Yours Means

Quick answer: Grip strength is one of the most reliable objective measures of overall muscle health and a well-established predictor of long-term health outcomes. Average scores decline with age and differ substantially between sexes. A result below age- and sex-matched norms may indicate sarcopenia risk or underlying nutritional and hormonal deficiencies worth investigating through biomarker testing.

Why Grip Strength is More Than a Gym Metric

Grip strength measurement takes less than a minute. What it reflects, however, extends well beyond hand function. Dozens of prospective studies have established grip strength as an independent predictor of cardiovascular outcomes, all-cause mortality, cognitive decline, and physical disability in aging populations. The European Working Group on Sarcopenia in Older People (EWGSOP) uses grip strength as a primary criterion in sarcopenia assessment precisely because it tracks whole-body muscle quality with a high degree of reliability.

Understanding your grip strength number in context — relative to your age, sex, and trajectory over time — is a starting point for evaluating muscle health. When scores fall below established norms, the appropriate follow-up is to understand why, which is where biomarker testing becomes relevant.

Grip Strength Norms by Age and Sex

The values below represent population-level reference norms for hand grip strength measured with a handheld dynamometer (in kilograms). These are composite reference ranges drawn from large normative studies including data from the National Health and Nutrition Examination Survey (NHANES) and published sarcopenia consensus guidelines. Individual variation is normal; these ranges serve as orientation points, not clinical thresholds.

Average grip strength for men (dominant hand, kg)

• 20–29 — Below average: under 40 kg, average: 40–56 kg, above average: over 56 kg
• 30–39 — Below average: under 41 kg, average: 41–57 kg, above average: over 57 kg
• 40–49 — Below average: under 39 kg, average: 39–55 kg, above average: over 55 kg
• 50–59 — Below average: under 35 kg, average: 35–51 kg, above average: over 51 kg
• 60–69 — Below average: under 30 kg, average: 30–45 kg, above average: over 45 kg
• 70–79 — Below average: under 26 kg, average: 26–40 kg, above average: over 40 kg
• 80+ — Below average: under 22 kg, average: 22–35 kg, above average: over 35 kg

Average grip strength for women (dominant hand, kg)

• 20–29 — Below average: under 25 kg, average: 25–36 kg, above average: over 36 kg
• 30–39 — Below average: under 25 kg, average: 25–37 kg, above average: over 37 kg
• 40–49 — Below average: under 24 kg, average: 24–35 kg, above average: over 35 kg
• 50–59 — Below average: under 21 kg, average: 21–32 kg, above average: over 32 kg
• 60–69 — Below average: under 18 kg, average: 18–28 kg, above average: over 28 kg
• 70–79 — Below average: under 15 kg, average: 15–24 kg, above average: over 24 kg
• 80+ — Below average: under 13 kg, average: 13–21 kg, above average: over 21 kg

Reference ranges derived from NHANES normative data and EWGSOP2 consensus. Measurement protocol (posture, dynamometer model, number of trials) affects results; values should be interpreted with measurement context in mind.

Clinical Cut-points Used in Sarcopenia Screening

The EWGSOP2 guidelines define probable sarcopenia as grip strength below 27 kg in men and below 16 kg in women, measured with a standard handheld dynamometer. These thresholds are used clinically as screening cut-points, not diagnostic criteria — a result below these values indicates that further assessment of muscle mass and physical performance is warranted, not that a diagnosis has been established. Providers interpret these numbers in the full clinical context of a patient's age, body composition, and functional status.

What Low Grip Strength May Indicate

Sarcopenia and age-related muscle loss

Grip strength declines at roughly 1–3% per year after the age of 30, with accelerating loss in later decades. This trajectory largely reflects sarcopenia — the progressive loss of skeletal muscle mass and function associated with aging. Sarcopenia is not an inevitable feature of aging; it is accelerated by physical inactivity, inadequate protein intake, and hormonal changes that are, in many cases, measurable through blood panels. IGF-1 (insulin-like growth factor 1), which mediates much of growth hormone's anabolic effect on muscle tissue, is one such marker. Research has established that IGF-1 is independently associated with skeletal muscle mass in older adults.

Low testosterone (in men)

Testosterone plays a central role in maintaining skeletal muscle mass and contractile function. Low testosterone is associated with accelerated loss of lean mass, reduced muscle cross-sectional area, and lower grip strength in men across age groups. Bioavailable testosterone — the fraction not bound to sex hormone-binding globulin — is a particularly relevant marker for assessing this relationship, as total testosterone can appear normal while bioavailable levels are meaningfully reduced. If grip strength is declining faster than age norms would predict, testosterone assessment is a reasonable part of the evaluation.

Nutritional deficiencies

Protein undernutrition, vitamin D deficiency, and inadequate caloric intake each impair muscle protein synthesis and can contribute to lower-than-expected grip strength. Vitamin D receptors are expressed in skeletal muscle, and deficiency has been associated with muscle weakness and impaired physical performance independent of age. 25-OH vitamin D is straightforward to measure and is a reasonable addition to any panel evaluating muscle health. Albumin and total protein provide additional context for nutritional status.

Anemia and iron deficiency

Reduced oxygen delivery to muscle tissue from anemia or iron deficiency directly limits the capacity for sustained muscular effort, producing measurable reductions in physical performance including grip strength. Ferritin is the most sensitive available marker for iron depletion and may reveal deficiency before hemoglobin falls outside the reference range.

Inflammation

Chronic low-grade inflammation is independently associated with accelerated muscle loss. Inflammatory cytokines — including those reflected by elevated hs-CRP — promote muscle protein catabolism and impair anabolic signaling. Elevated hs-CRP in the context of declining grip strength is worth noting as a potential contributing factor.

What Affects Grip Strength Measurement Accuracy

Grip strength results are sensitive to measurement technique. Factors that affect the value include: posture during testing (seated versus standing), elbow angle (90 degrees is standard), the specific dynamometer model used (Jamar is most widely validated), the number of trials averaged, and hand dominance. Most published norms are for the dominant hand. Using three trials and recording the mean is the most reproducible approach. A single measurement taken under inconsistent conditions is less informative than a trend tracked across repeated measurements under the same protocol.

Biomarkers to Assess When Grip Strength is Below Norms

• IGF-1 — Growth hormone axis activity; independently associated with muscle mass
• 25-OH Vitamin D — Muscle receptor activity; deficiency linked to muscle weakness
• Ferritin — Iron storage; supports oxygen delivery to muscle tissue
• Hemoglobin — Oxygen-carrying capacity; anemia reduces physical performance
• hs-CRP — Chronic inflammation; accelerates muscle protein catabolism
• Fasting glucose + HbA1c — Blood sugar status; insulin resistance impairs muscle metabolism

Superpower's Baseline Blood Panel includes ferritin, vitamin D, hemoglobin, fasting glucose, HbA1c, and hs-CRP, covering the most common nutritional and metabolic contributors to reduced muscle performance.

Frequently Asked Questions

What is a good grip strength score for my age?

See the tables above for age- and sex-matched reference ranges. As a general orientation: scores at or above the "average" range for your age and sex are consistent with normal muscle function. The EWGSOP2 clinical cut-points (27 kg for men, 16 kg for women) define the threshold below which further muscle health assessment is recommended. Your provider can interpret your result in the full context of your health history and body composition.

Does grip strength actually predict longevity?

Yes — grip strength is one of the most robust physical performance predictors of all-cause mortality in population studies. Large prospective cohort data have consistently linked lower grip strength to higher risk of cardiovascular events, cognitive decline, and early mortality. It is not a cause of these outcomes; it functions as a marker of overall musculoskeletal health and physiological reserve.

How do I measure grip strength at home?

A calibrated handheld dynamometer (such as the Jamar or a validated digital equivalent) is required for accurate measurement. Smartphone grip apps are not validated and should not be used for clinical comparison. Testing should be done seated with the elbow at 90 degrees, conducting three trials per hand and recording the mean. Non-dominant hand values are typically 5–10% lower than dominant hand values.

Can grip strength improve with training?

Yes. Resistance training that challenges the forearm and hand musculature — including deadlifts, rows, and direct grip work — can produce meaningful improvements in grip strength at any age. Progressive resistance training also supports broader muscle mass retention and has favorable effects on metabolic markers including insulin sensitivity and IGF-1. A qualified exercise professional can advise on program design.

What blood tests are relevant to grip strength?

Grip strength below age-matched norms warrants assessment of markers related to muscle function: IGF-1, vitamin D, ferritin, hemoglobin, and hs-CRP. Testosterone and fasting insulin may also be relevant depending on age and clinical context.